Success Stories: EB-1A Approved for a Postdoctoral Fellow in Georgia in the Field of Cell Biology
Client’s Testimonial:
Thank you very much! It is really good news! I appreciate your kind help!
On February 13th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Cell Biology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Georgia
Approval Notice Date: February 13th, 2015
Processing Time: 42 days (29 days after Requesting Premium Processing; includes RFE Response Time)
In this case we were offered the opportunity to work with a cell biologist from China whose highly specialized work focused on elucidating the underlying biological pathways and mechanisms in various diseases (including diabetes and atherosclerosis) as well as the underlying mechanisms of animal growth and development. He had produced 20 peer-reviewed journal articles, 4 patents and given 5 presentations at national and international conferences; altogether our client’s work had received no fewer than 222 citations from independent and leading researchers at prestigious institutions and organizations around the world, showing its major significance within his field. He had also reviewed 12 manuscripts for 1 prominent, internationally-circulated journal. An independent recommender endorsed our client’s superior level of expertise: “… [Client’s] more recent manuscripts are on health issues, such as diabetes, that afflict and claim the lives of a huge cross-section of the population of the United States and the world. He has made himself irreplaceable in his bids to improve public health, and I hope that he is respected accordingly.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Cell Biology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 42 days (29 days after Requesting Premium Processing, including RFE Response Time).

